Packer, M., Anker, S. D., Butler, J., Filippatos, G., Pocock, S. J., Carson, P., . . . Chuquiure, E. (2020). Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. New England Journal of Medicine, 383(15), 1413. https://doi.org/10.1056/NEJMoa2022190
Chicago Style (17th ed.) CitationPacker, M., et al. "Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure." New England Journal of Medicine 383, no. 15 (2020): 1413. https://doi.org/10.1056/NEJMoa2022190.
MLA (9th ed.) CitationPacker, M., et al. "Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure." New England Journal of Medicine, vol. 383, no. 15, 2020, p. 1413, https://doi.org/10.1056/NEJMoa2022190.
Warning: These citations may not always be 100% accurate.